Dr. Gerard Abood

Get to Know Dr. Gerard Abood

Surgical oncologist Dr. Gerard Abood is part of a multidisciplinary team at Loyola University Medical Center working together to treat peritoneal mesothelioma and other abdominal malignancies.

The team includes medical oncologists, pathologists, radiation oncologists and nurses who meet regularly to discuss each patient and to personalize care.

They treat pancreatic, liver, colorectal, stomach, esophageal, bowel and bile duct cancers, often using minimally invasive techniques that have become a safe and effective option.

Abood also combines cytoreduction with hyperthermic intraperitoneal chemotherapy, known as HIPEC, for advanced-stage cancers. The combination has helped turn peritoneal mesothelioma from an incurable disease into one more manageable.

The combination procedure is used only at select treatment centers such as the Cardinal Bernardin Cancer Center, part of Loyola University Medical Center in Maywood, just outside of Chicago.

Close Button

Full Name

Diagnosis Please Select Mesothelioma Asbestosis Lung Cancer Other Unknown

Zip Code

Continue

Email

Phone Number

Preferred Method of Contact Please Select Call Text

Back Get Help Now

By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Full Name

Specialties of Dr. Gerard Abood

• Cytoreductive surgery
• HIPEC
• Robotic surgery
• Whipple surgery
• Liver tumors
• Peritoneal mesothelioma
• Bile duct disorders
• Gastrointestinal diseases

Dr. Gerard Abood’s Experience and Medical Education

• University of Pittsburgh Medical Center (Fellowship)
• Loyola University Medical Center (Residency)
• Ohio State University College of Medicine (M.D.)

Awards and Certifications

• Board certified in surgery
• CMS Meaningful Use Stage 1 Certification
• EpicCare Ambulatory EMR, Epic Systems Corporation

Publications of Dr. Gerard Abood

• Patel, D.J. et al. (2020, July 30). Adjuvant systemic therapy for small bowel gastrointestinal stromal tumor (GIST): Is there a survival benefit after R0 resection? Surgery.
• Eguia, E. et al. (2018, November). What are the predictors that can help identify safe removal of drains following pancreatectomy? The American Journal of Surgery.
• Fisichella, P.M. et al. (2013, October 10). Laparoscopic Splenectomy: Perioperative Management, Surgical Technique, and Results. Journal of Gastrointestinal Surgery.